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Abstract: The work in this article addresses a problem posed by Dr. Maria
Salvato to the CODEE community. The task was to model costs associated
with varying vaccination strategies for the Avian Flu virus (H5N1) on chicken
populations. The vaccination strategies proposed included vaccination vary-
ing proportions of the flock with live virus vaccine, dead virus vaccine, and
no vaccination. This article encompasses the construction of a model for the
problem using a modification to the SIER model and the subsequent analy-
sis of that model. The analysis of the model revealed the most cost effective
vaccination strategy to be vaccination of half the flock with dead virus vaccine.
1 Introduction
In the past month, March–April 2013, outbreaks of avian flu (H5N1) in humans have been
reported in China, Egypt, Cambodia, Bhutan, Indonesia, Israel, Myanmar, Bangladesh,
Vietnam, and India1. H5N1 virus has infected over 500 million poultry since 1997 leading
to their obligatory extermination [9].
Despite the widespread awareness and impact of the virus, epidemiological models of
the disease are lacking both due to scarce experimental data to support parameters and
the difficulty in development of a conclusive model. One recent model that collected data
on chickens vaccinated with a dead vaccine used a Susceptible-Infected-Recovered (SIR)
based approach, which we shall similarly implement in our study [3].
There are two primary ways to vaccinate chickens against avian flu: 1) Using vacci-
nations comprised of dead virus particles that constitute a sufficient library to develop
complete resistance to the infectious form of the virus, or 2) through exposure to a weak-
ened but live sample of virus that is less harmful and will build some resistance so that
when exposed to the virulent strain, the infection and death rate is less severe. The
1http://www.who.int/influenza/human_animal_interface/H5N1_avian_influenza_
update200412.pdf
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cost and time required to manufacture dead H5N1 vaccines is greater than the cost for
producing live-attenuated forms, making them expensive for use in developing countries.
Viral vaccines for poultry are commonly produced from eggs. It has been estimated
that, since the ratio of virus produced per egg is the limiting cost in the production of
dead vaccines [2] and production of live vaccines has been accelerated by a magnitude of
over 10,000 for H1N1 vaccine production in eggs [5], the production of live attenuated
vaccines can be estimated to cost 1/10,000th of that of dead vaccines. This makes the cost
of producing a live attenuated vaccine nearly negligible. It was suspected that we would
find that the cost of a treatment strategy for a flock of chickens would be lower with the
live attenuated vaccine.
Through simulation with our modified SIR model we found that the most cost effective
prevention strategy for a flock of 10,000 broiler chickens was, surprisingly, the use of
dead vaccine on half of the chicken population. This was due to the high cost of higher
death rates to the disparity in resistance from the different vaccine strategies and the fact
that the majority of the cost of vaccination is, in fact, due to transport, labor, and other
costs beyond production.
2 The Standard Incidence Model
The Standard Incidence Model is a basic form of horizontal incidence used in the classic
SIR problem [7].
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In this model we let N be the total population size, which is fixed for all time (in our
case we let N = 10, 000 chickens). We define S(t) as the number of susceptible individuals
at time t , and further let s(t) = S(t)/N , so s(t) is the susceptible fraction. Similarly, I (t) is
the number of infected chickens at time t and i(t) = I (t)/N is the infectious fraction.
We now let β be the average number of contacts sufficient for transmission with units
of chickens/(unit time). If we say that βI (t)/N = βi(t) is the average number of contacts
with infectives of a suscepible per unit time, then we can let βIS/N = βNi(t)s(t) be the
number of new cases per unit time due to the number of susceptibles.
Lastly, we let R(t) be the number of chickens in the Recovered/Removed compartment
of our model at time t . It is typical to make further assuptions to determine the movement
from the I to R compartment with a term like γ I in an ordinary differential equation model.
It has been shown [6] that these terms correspond to exponentially distributed wait times
in each of the compartments, with recovery rate γ I (corresponding to P(t) = e−γ t ) being
the fraction of infected chickens remaining after t amount of time has passed since they
became infected. This makes 1/γ the mean infection period (from the definition of an
exponential distribution).
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Ourmodel has been adapted from this basic model to best incorporate the experimental
data available and to provide analysis that better helps solve the optimization problem of
vaccination.
3 Adaptation of the Standard Incidence Model
Adapting the general SIR model to better fit the case of the Avian Flu, we added a fourth
compartment to our model, D(t), that contains those chickens that die due to infection.
Separating the recovered chickens from the dead allowed us to better assess the success
of different vaccination programs.
Second, when a susceptible bird comes into contact with an infected and receives
the virus, it first becomes “exposed,” before becoming infected. Chickens in this stage
are undergoing virus replication, in what is known as the incubation or latent period.
These birds have the virus, but are not, yet, showing signs of the disease nor are they
contagious. Once the virus has replicated to a sufficient level, the birds move to the
infected compartment where they too can spread the virus. Since the latent period of the
disease in chickens is roughly the same length of time as the period of infectiousness2 it
must be accounted for. So we add a fifth compartment, E(t), for exposed chickens who
are not yet infectious.
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In this model, the definition of our β parameter is the same. We added two additional
parameters and similarly adjusted γ . First, we let 1/ε be the average latent period, so
that chickens move from the E to I compartment at a rate of εE. Next, once chickens
are infected, we assume that they live in this state for a number of days based upon
experimental data for the infectious period and then will either recover with probability
P(recover), or die with probability 1− P(recover). Therefore, we let µ be the rate at which
chickens die, which is equal to (1 − P(recover)) divided by the average length of infection.
Similarly, we letγ be the rate at which chickens recover, whereγ equals P(recover) divided
2http://www.oie.int/fileadmin/Home/fr/Health_standards/tahm/2.03.04_AI.pdf
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by the average length of infection. We can therefore establish the following dynamics:
dS
dt
= −βIS/N (3.1a)
dE
dt
= βSI/N − εE (3.1b)
dI
dt
= εE − µI − γ I (3.1c)
dR
dt
= γ I (3.1d)
dD
dt
= µI (3.1e)
Since exposing chickens to live vaccines does not prevent them from becoming infected
with the virulent strain, but rather lessens the intensity of infection (and in this way the
value of the model parameters change), this SEIRD model is representative of both the
unvaccinated and live attenuated vaccination cases we want to explore.
4 Incorporating the Dead Virus Vaccine
The previous model works well for estimating the effect of using live attenuated vaccines
or simply leaving an entire flock unvaccinated. If dead virus vaccines were used within the
flock, the chickens receiving the vaccine would become immune to the virulent strain of
flu, moving them directly from the S to R category before an outbreak even occurs. We can
choose and optimize the proportion of the flock to vaccinate, ρ, leaving the unvaccinated
birds as the new initial susceptible number to pass through the previous model, S1. It
is costly to vaccinate every bird and also unnecessary. Herd immunity occurs when
enough of a population is vaccinated to stop the spread of disease by reducing the number
of potential infectious carriers to a proportionally inconsequential number. Often, if
only 80–90% of a population is immunized, the disease is halted despite the remaining
susceptible individuals.
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By adjusting our SEIRD model above to include direct passage from S to R compart-
ments via dead virus vaccination prior to outbreak, we can adjust and optimize ρ in order
to identify herd immunity levels and seek cost optimal solutions. Since the unvaccinated
birds are the only ones that will pass through the exposed, infected, and dead classes, we
use the same dynamic equations and parameters as in the unvaccinated case, but start
with different initial susceptible levels.
5 Determining Parameters
hree previous research studies had experimentally identified each of parameters we were
seeking in our model using similar methods so that they could be compared [3, 10, 11].
These methods involved exposing over 10 chickens to different treatment conditions and
housing them pair-wise in exposed cages, with each treatment group in different rooms.
TIn a study by van Boven et al, 8 experiments consisting of 11 trials each were carried
out. In each trial an inoculated bird was placed in a cage with an uninfected contact bird,
and the transmission chain was monitored daily by virus isolation performed on swabs
taken from the trachea and cloaca [3]. Two experiments involved flocks of 22 unvaccinated
chickens housed in paired cages, and the remaining 6 experiments used chickens given
dead virus vaccinations. In this way, the experimenters were able to conclude that all
unvaccinated birds who became infected died after an average of 2 days, and prior to
death experienced a one day latent period. Additionally, they calculated that β in this
setting is 0.8. Furthermore, this research concluded that no transmission occurred among
chickens vaccinated with dead virus vaccines.
Next, an experiment was designed by de Jong et al to determine the inoculation dose
for live attenuated vaccination with H5N1 that involved vaccination of 4 groups of 22
chickens each with varying concentrations of viral particles in order to determine the
lowest β parameter achievable [11]. This was determined to be 0.9. We averaged survival
data for the vaccination strategies closest to the lowest beta value in order to assume that
3 out of every 10 chickens die due to infection, and recorded that the latent period in this
case doubled.
Multiple live attenuated vaccines have been suggested since the de Jong paper in 2011.
Parameter No Vaccination Live Attenuated Vaccine Dead Virus
β .8 .9 .8
Av. Latent Period .25 days .5 days .25 days
Av. Infectious Period 2 days 2 days 2 days
Survival Rate 0% 70% 100%
Death Rate 100% 30% 0%
ε 1/1 1/2 1/1
µ 1 (1/2) .3 (1/2) .7 (1/2)
γ 0 .7 (1/2) 0
Table 1: Relevant parameters for our model. The first and last columns of values are from
[3]. The middle column uses parameters from [10, 11].
5
The paper we chose to base our assumptions/estimations of live attenuated virus parame-
ters upon was a more recent paper which showed that H1N1 and H2N1 live attenuated virus
can be used to vaccinate against H5N1 [10], but only with partial heterologous protection.
Unvaccinated chickens that were exposed to H5N1 virus showed signs of disease in half
the time it took for chickens that had been vaccinated with the live-attenuated virus.
Consequently, we chose a latent period (β) that is twice as long for the live-attenuated
vaccinated chickens as for the unvaccinated chickens. Identical to the de Jong paper,
this vaccination strategy showed a 7/10 survival after exposure to H5N1 contacts and the
chickens showed no signs of clinical disease due to the H1N1 or H2N1 viruses and shed no
viral particles associated with H1N1 or H2N1 [11].
6 Survival Results
Using Mathematica to solve the system of differential equations and the parameters
discussed above and values S(0) = 9990, E(0) = 10, and I (0) = D(0) = R(0) = 0, (corre-
sponding to an initial population of 10,000 chickens with 10 newly infected individuals)
we were able to generate the following results.
We saw that when our flock is left unvaccinated, the highest rate of death corresponds
with the peak in infectious chickens (Figure 1). Eventually, the number of exposed and
infected chickens decreases as the disease runs its course and more chickens die. As
infected and exposed categories go to zero, we see that we are left with approximately
35% of our flock never exposed to the disease and 65% dead due to infection.
Figure 1: Equilibria for dead and surviving birds across one year post initial outbreak
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When we simulated vaccinating the flock with live attenuated virus, we find that only
22% of the flock dies (Figure 2). We are left with 78% of the flock surviving at the end of the
epidemic, 51% of which became infected but recovered, and 27% which escaped exposure
entirely. Thus, by using live attenuated vaccination methods, the physical loss within the
flock is about one-third of the physical loss experienced when the flock is left unvaccinated.
When we examined the effects of the dead vaccine, we varied the proportion that we
Figure 2: Equilibria for dead, recovered, and surviving susceptible live attenuated vacci-
nated birds in across one year post initial outbreak
initially vaccinated, ρ, giving us differing initial values of S when an outbreak occurs. For
example if we first vaccinate 50% of our flock of 10,000 as a preventative measure, then
these 5,000 vaccinated birds are moved directly to the recovered compartment. Thus, in
the event that the flock is exposed to the virulent H5N1 virus, S1 within our SEIRD model
is now 5,000, less the number of chickens that initially contract the virus. Given smaller
initial susceptible populations after some proportion is removed through vaccination, the
death rate among the unvaccinated significantly decreases. The corresponding losses for
each vaccinated proportion are discussed in the next section.
7 Cost Analysis and Conclusions
Direct costs of vaccination of poultry have been accounted for in previous studies. The
average cost of a broiler chicken was taken to be 1.98858USD [1]. The fact that 3.8% annual
mortality is expected in broiler chicken flocks was also accounted for within the surviving
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group3. The cost of dead vaccine per chicken has been reported to be 0.10 USD for
transportation, supplies, and personnel, and 0.04 USD for the cost of the vaccine, totaling
to 0.14 USD [8]. The cost of the live attenuated vaccine was considered to be negligible
compared to the dead vaccine and so the total cost per chicken for live attenuated vaccine
was assumed to be 0.10 USD for similar transportation and personnel reasons.
Figure 3: Direct and predicted costs associated with preventative care strategies for H5N1
in a population of 10,000 chickens
We saw that both vaccination strategies are less expensive than no vaccination due
to the cost of the majority of the unvaccinated flock dying due to outbreak (Figure 3).
We saw the total costs of live vaccination of the entire population to be less than half
of that without vaccination. Surprisingly, the dead vaccine, which is more expensive
to produce, was roughly three times more cost effective than the live vaccine due to its
superior efficacy in saving chicken lives (a major expense).
Varying distribution proportions of the dead vaccine, we saw that the range of 40–60%
vaccination lead to a sufficiently small susceptible population so that few of the chickens
died since the initial infection could not spread far due to a low number of potential
disease carriers. We also saw that herd immunity was reached at roughly 80% vaccination
of the whole chicken population with dead virus, at which point it was predicted that
no chickens beyond the initial infection were to become infected. This value for herd
immunity was in perfect agreement with the experimental outbreak performed by Bauma
et al [3]. These findings indicate that there may be an optimal economic vaccination
window below 80%, which also attenuates spread of the disease and possibility of human
infection.
3http://www.nationalchickencouncil.org/about-the-industry/statistics/
u-s-broiler-performance/
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Our model first serves to describe those parameters that most affect the prevention and
transmission of Avian Flu. Simultaneously, our model allows for some recommendation
as to current practice, but with severe hesitation due to the limitations of the model. Our
model looks at isolated flocks and an unchanging virus, but one of the greatest threats
of the Avian flu is its ability to mutate and defy vaccination attempts. A recent study
examined the evolution within clades of H1N1, and suggested that rates of virus evolution
increase in populations with higher vaccination rates [4]. A further model that would
help to inform the application of our flock-based model would be one that looks at the
effect of vaccinating portions of the country and incorporates the mutating nature of the
disease.
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